Man Group PLC Medpace Holdings, Inc. Transaction History

Man Group PLC

$36 Billion
Q3 2024

A detailed history of Man Group PLC transactions in Medpace Holdings, Inc. stock. As of the latest transaction made, Man Group PLC holds 123,587 shares of MEDP stock, worth $43.2 Million. This represents 0.11% of its overall portfolio holdings.

Number of Shares

123,587

Previous 127,754 3.26%

Holding current value

$43.2 Million

Previous $52.6 Million 21.67%

% of portfolio

0.11%

Previous 0.14%

27 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$320.58 - $457.29 $1.34 Million - $1.91 Million	-4,167 Reduced 3.26%	123,587 $41.2 Million
Q2 2024 Aug 14, 2024	SELL	$372.0 - $424.34 $3.08 Million - $3.51 Million	-8,274 Reduced 6.08%	127,754 $52.6 Million
Q1 2024 May 15, 2024	SELL	$284.87 - $413.31 $9.95 Million - $14.4 Million	-34,917 Reduced 20.43%	136,028 $55 Million
Q4 2023 Feb 14, 2024	BUY	$227.52 - $312.68 $2.07 Million - $2.84 Million	9,081 Added 5.61%	170,945 $52.4 Million
Q3 2023 Nov 14, 2023	BUY	$233.98 - $281.67 $8.66 Million - $10.4 Million	36,998 Added 29.63%	161,864 $39.2 Million
Q2 2023 Aug 14, 2023	BUY	$187.26 - $240.17 $5.74 Million - $7.36 Million	30,631 Added 32.5%	124,866 $30 Million
Q1 2023 May 15, 2023	SELL	$174.31 - $239.52 $6.89 Million - $9.46 Million	-39,516 Reduced 29.54%	94,235 $17.7 Million
Q4 2022 Feb 14, 2023	BUY	$153.06 - $226.57 $5.64 Million - $8.35 Million	36,856 Added 38.04%	133,751 $28.4 Million
Q3 2022 Nov 14, 2022	BUY	$145.13 - $182.49 $4.14 Million - $5.2 Million	28,511 Added 41.69%	96,895 $15.2 Million
Q2 2022 Aug 15, 2022	BUY	$130.2 - $168.03 $1.28 Million - $1.65 Million	9,807 Added 16.74%	68,384 $10.2 Million
Q1 2022 May 16, 2022	SELL	$138.87 - $214.31 $2.41 Million - $3.72 Million	-17,348 Reduced 22.85%	58,577 $9.58 Million
Q4 2021 Feb 14, 2022	SELL	$182.74 - $227.9 $2.43 Million - $3.03 Million	-13,286 Reduced 14.89%	75,925 $16.5 Million
Q3 2021 Nov 15, 2021	BUY	$170.18 - $198.21 $1.74 Million - $2.03 Million	10,228 Added 12.95%	89,211 $16.9 Million
Q2 2021 Aug 16, 2021	SELL	$158.62 - $194.3 $3.75 Million - $4.6 Million	-23,649 Reduced 23.04%	78,983 $14 Million
Q1 2021 May 17, 2021	SELL	$132.02 - $168.26 $13 Million - $16.6 Million	-98,848 Reduced 49.06%	102,632 $16.8 Million
Q4 2020 Feb 16, 2021	SELL	$109.38 - $149.19 $11 Million - $15 Million	-100,353 Reduced 33.25%	201,480 $28 Million
Q3 2020 Nov 16, 2020	BUY	$92.95 - $130.61 $7.77 Million - $10.9 Million	83,572 Added 38.29%	301,833 $33.7 Million
Q2 2020 Aug 14, 2020	SELL	$68.08 - $95.68 $527,960 - $741,998	-7,755 Reduced 3.43%	218,261 $20.3 Million
Q1 2020 May 15, 2020	SELL	$61.71 - $101.95 $8.71 Million - $14.4 Million	-141,222 Reduced 38.46%	226,016 $16.6 Million
Q4 2019 Feb 18, 2020	BUY	$70.08 - $84.64 $12.9 Million - $15.6 Million	184,221 Added 100.66%	367,238 $30.9 Million
Q3 2019 Nov 14, 2019	SELL	$62.38 - $85.89 $10.5 Million - $14.5 Million	-169,112 Reduced 48.03%	183,017 $15.4 Million
Q2 2019 Aug 14, 2019	BUY	$53.64 - $65.42 $1.66 Million - $2.02 Million	30,862 Added 9.61%	352,129 $23 Million
Q1 2019 May 15, 2019	BUY	$49.38 - $70.58 $2.07 Million - $2.96 Million	41,927 Added 15.01%	321,267 $18.9 Million
Q4 2018 Feb 14, 2019	SELL	$46.97 - $63.98 $10.2 Million - $13.9 Million	-217,528 Reduced 43.78%	279,340 $14.8 Million
Q3 2018 Nov 14, 2018	BUY	$43.25 - $63.74 $9.79 Million - $14.4 Million	226,300 Added 83.64%	496,868 $29.8 Million
Q2 2018 Aug 14, 2018	SELL	$34.03 - $45.46 $304,806 - $407,185	-8,957 Reduced 3.2%	270,568 $11.6 Million
Q1 2018 May 15, 2018	BUY	$32.03 - $39.05 $8.95 Million - $10.9 Million	279,525 New	279,525 $9.76 Million

Others Institutions Holding MEDP

# of Institutions

617

Shares Held

25.1M

Call Options Held

42.8K

Put Options Held

207K

View Full List

About Medpace Holdings, Inc.

Ticker MEDP
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 31,099,900
Market Cap $10.9B
Description
Medpace Holdings, Inc. provides clinical research-based drug and medical device development services in North America, Europe, and Asia. It offers a suite of services supporting the clinical development process from Phase I to Phase IV in various therapeutic areas. The company also provides clinical development services to the pharmaceutical, bi...

More about MEDP

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Man Group PLC, based on Form 13F filings with the SEC.

News

Stay updated on Man Group PLC with notifications on news.

Account